You have 9 free searches left this month | for more free features.

11C-PS13

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Sclerosis Trial run by the NIMH (11C-MCI, 11C-PS13)

Recruiting
  • Multiple Sclerosis
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023

Depression Trial run by the NIMH (11C-MCI, 11CPS13)

Recruiting
  • Depression
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Novel PET Radioligand to Image Cyclooxygenase-1 (COX-1)

Recruiting
  • Normal Physiology
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Uncommon Presentations and/or Uncommon Diseases Associated With

    Recruiting
    • Cardiomyopathy
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    People Who Have Genetic Changes and Features of Autism: Simons

    Recruiting
    • 16P11.2 Deletion Syndrome
    • +184 more
      • New York, New York
      • +1 more
      Jan 6, 2023

      Amyloidosis, Primary, Cardiomyopathy Trial in Boston (F-18 florbetapir/C-11 acetate PET, MRI, N-13 ammonia PET)

      Recruiting
      • Amyloidosis, Primary
      • Cardiomyopathy
      • F-18 florbetapir/C-11 acetate PET
      • +2 more
      • Boston, Massachusetts
        Brigham and Womens' Hospital
      Oct 23, 2022

      Infants Aged 0 Days to 13 Months Scheduled for Elective Surgery Trial in Seoul (conventional ventilation, group C, pressure

      Not yet recruiting
      • Infants Aged 0 Days to 13 Months Scheduled for Elective Surgery
      • conventional ventilation, group C
      • pressure support, group PS
      • Seoul, Korea, Republic of
        Yonsei University Health System, Severance Hospital
      May 9, 2022

      Healthy Volunteers Trial in Nottingham ([12C] RO7049389, [13C] RO7049389, [14C] RO7049389)

      Completed
      • Healthy Volunteers
      • [12C] RO7049389
      • +2 more
      • Nottingham, United Kingdom
        Quotient Sciences
      Jul 21, 2021

      Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

      Completed
      • Adult Acute Megakaryoblastic Leukemia (M7)
      • +13 more
      • Philadelphia, Pennsylvania
        Thomas Jefferson University
      Feb 2, 2023

      Atopic Dermatitis Trial in Canada, United States (Abrocitinib)

      Recruiting
      • Atopic Dermatitis
      • Fountain Valley, California
      • +8 more
      Jan 25, 2023

      Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

      Terminated
      • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
      • +8 more
      • Duarte, California
        City of Hope Medical Center
      Mar 28, 2022

      Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

      Completed
      • Adult Acute Megakaryoblastic Leukemia (M7)
      • +15 more
      • trebananib
      • +3 more
      • Buffalo, New York
      • +1 more
      Sep 8, 2022

      Chronic Right-Sided Heart Failure, Pulmonary Arterial Hypertension, Pulmonary Hypertension, Primary, 2 Trial in Ottawa (drug,

      Recruiting
      • Chronic Right-Sided Heart Failure
      • +5 more
      • Ottawa, Ontario, Canada
        University of Ottawa Heart Institute
      Nov 19, 2021

      Solid Tumors Trial in Japan (E7389-LF, Nivolumab)

      Active, not recruiting
      • Solid Neoplasms
      • Nagoya, Aichi, Japan
      • +18 more
      Jan 31, 2023

      Mantle Cell Lymphoma Trial in United States (Acalabrutinib, Bortezomib, Cyclophosphamide)

      Recruiting
      • Mantle Cell Lymphoma
      • New Orleans, Louisiana
      • +5 more
      Dec 13, 2022

      Chronic Hand Eczema Trial in Canada, Spain, United Kingdom (Delgocitinib, Cream vehicle)

      Recruiting
      • Chronic Hand Eczema
      • Darlinghurst, Australia
      • +25 more
      Dec 12, 2022

      Anus Tumors, Carcinoma, Squamous Cell, Anus Diseases Trial (Paclitaxel, Capecitabine, Mitomycins)

      Unknown status
      • Anus Neoplasms
      • +5 more
      • (no location specified)
      Feb 7, 2021

      Brodalumab in Plaque Psoriasis to Understand Impact on Quality

      Recruiting
      • Psoriasis
      • Brodalumab
      • Matched cohort
      • Calgary, Alberta, Canada
      • +33 more
      Oct 8, 2022

      Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

      Terminated
      • Adult Acute Megakaryoblastic Leukemia (M7)
      • +15 more
      • fludarabine phosphate
      • +4 more
      • New Brunswick, New Jersey
        Rutgers Cancer Institute of New Jersey
      Aug 20, 2021

      Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute

      Recruiting
      • Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
      • +9 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 27, 2021

      Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

      Completed
      • Adult Acute Megakaryoblastic Leukemia (M7)
      • +16 more
      • choline magnesium trisalicylate
      • +3 more
      • New Brunswick, New Jersey
        Rutgers Cancer Institute of New Jersey
      Aug 20, 2021

      Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

      Not yet recruiting
      • Anatomic Stage III Breast Cancer AJCC v8
      • +14 more
      • Biopsy
      • +25 more
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Jul 12, 2022

      Plaque Psoriasis Trial in Canada, United States (Roflumilast Cream 0.3%, Roflumilast Cream 0.15%, Vehicle Cream)

      Completed
      • Plaque Psoriasis
      • Roflumilast Cream 0.3%
      • +2 more
      • Beverly Hills, California
      • +29 more
      Aug 31, 2022

      NSCLC Stage III Trial (radiotherapy, Platinum-Based Drug, Immunotherapy)

      Not yet recruiting
      • Non-small Cell Lung Cancer Stage III
      • radiotherapy
      • +3 more
      • (no location specified)
      Sep 10, 2023

      Type 2 Diabetes Trial in Argentina, China, Mexico (LY900014, Insulin Lispro, Insulin Glargine)

      Completed
      • Type 2 Diabetes Mellitus
      • Buenos Aires, Ar-c, Argentina
      • +40 more
      Jan 11, 2022